Related Experiment Video
Updated: May 31, 2025
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy
Shixu Song1,2, Jialing Gan1,2, Qiuyue Long1,2
1Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China.
Abstract:
The persistent threat of COVID-19, particularly with the emergence of new variants, underscores the urgency for innovative therapeutic strategies beyond conventional antiviral treatments. Current immunotherapies, including IL-6/IL-6R monoclonal antibodies and JAK inhibitors, exhibit suboptimal efficacy, necessitating alternative approaches. Our review delves into the significance of NAD+ metabolism in COVID-19 pathology, marked by decreased NAD+ levels and upregulated NAD+-consuming enzymes such as CD38 and poly (ADP-ribose) polymerases (PARPs). Recognizing NAD+'s pivotal role in energy metabolism and immune modulation, we propose modulating NAD+ homeostasis could bolster the host's defensive capabilities against the virus. The article reviews the scientific rationale behind targeting NAD+ pathways for therapeutic benefit, utilizing strategies such as NAD+ precursor supplementation and enzyme inhibition to modulate immune function. While preliminary data are encouraging, the challenge lies in optimizing these interventions for clinical use. Future research should aim to unravel the intricate roles of key metabolites and enzymes in NAD+ metabolism and to elucidate their specific mechanisms of action. This will be essential for developing targeted NAD+ therapies, potentially transforming the management of COVID-19 and setting a precedent for addressing other infectious diseases.
Insights
Investigating nicotinamide adenine dinucleotide (NAD+) metabolism in COVID-19 reveals potential therapeutic targets. Modulating NAD+ pathways may enhance immune defense against SARS-CoV-2, offering new treatment avenues.
Area of Science:
- Biochemistry
- Immunology
- Virology
Background:
- COVID-19 presents an ongoing global health challenge, with limited therapeutic options beyond antivirals.
- Current immunotherapies show suboptimal efficacy against SARS-CoV-2 and its variants.
- NAD+ metabolism is dysregulated in COVID-19, with decreased NAD+ levels and increased consumption by enzymes like CD38 and PARPs.
Purpose of the Study:
- To review the role of NAD+ metabolism in COVID-19 pathogenesis.
- To explore the therapeutic potential of modulating NAD+ homeostasis for COVID-19 treatment.
- To identify strategies for targeting NAD+ pathways to enhance host immunity.
Main Methods:
- Literature review focusing on NAD+ metabolism and its connection to COVID-19.
- Analysis of scientific literature on immunotherapies and their limitations.
- Examination of proposed therapeutic strategies involving NAD+ precursors and enzyme inhibitors.
Main Results:
- NAD+ plays a critical role in cellular energy metabolism and immune function.
- Decreased NAD+ levels and increased consumption are observed in COVID-19 patients.
- Targeting NAD+ pathways offers a promising, novel therapeutic strategy.
Conclusions:
- Modulating NAD+ homeostasis may significantly enhance the host's immune response to COVID-19.
- NAD+ precursor supplementation and enzyme inhibition are potential therapeutic interventions.
- Further research is crucial to optimize NAD+ therapies for clinical application and other infectious diseases.
